loadpatents
name:-0.023835897445679
name:-0.01079797744751
name:-0.0057089328765869
Her; Jeng-Horng Patent Filings

Her; Jeng-Horng

Patent Applications and Registrations

Patent applications and USPTO patent grants for Her; Jeng-Horng.The latest application filed is for "antibodies for t-cell activation".

Company Profile
5.9.17
  • Her; Jeng-Horng - Taipei TW
  • HER; Jeng-Horng - San Jose CA
  • Her; Jeng-Horng - Sunnyvale CA
  • HER; Jeng-Horng - Taipei City TW
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Fusion protein comprising a ligand binding domain of VEGF and PDGF
Grant 11,299,531 - Zen , et al. April 12, 2
2022-04-12
Antibodies For T-cell Activation
App 20200407456 - YOU; Jhong-Jhe ;   et al.
2020-12-31
Bifunctional Proteins Combining Checkpoint Blockade for Targeted Therapy
App 20200299389 - Her; Jeng-Horng ;   et al.
2020-09-24
Monospecific and Bispecific Proteins with Immune Checkpoint Regulation for Cancer Therapy
App 20200270357 - You; Jhong-Jhe ;   et al.
2020-08-27
Protein Inhibitors To Complement And Vegf Pathways And Methods Of Use Thereof
App 20180312819 - HER; Jeng-Horng ;   et al.
2018-11-01
Protein inhibitors to complement and VEGF pathways and methods of use thereof
Grant 9,988,611 - Her , et al. June 5, 2
2018-06-05
Fusion Protein Comprising A Ligand Binding Domain Of Vegf And Pdgf
App 20170369552 - ZEN; Kevin ;   et al.
2017-12-28
Protein Inhibitors To Complement And Vegf Pathways And Methods Of Use Thereof
App 20150079084 - Her; Jeng-Horng ;   et al.
2015-03-19
GPCR Expressing Cell Lines and Antibodies
App 20120219968 - Mancebo; Helena S. ;   et al.
2012-08-30
GPCR expression vector
Grant 8,178,346 - Mancebo , et al. May 15, 2
2012-05-15
Detection of molecular interactions by .beta.-lactamase reporter fragment complementation
Grant 8,148,110 - Blau , et al. April 3, 2
2012-04-03
Antibody specificity transfer using minimal essential binding determinants
Grant 7,981,843 - Flynn , et al. July 19, 2
2011-07-19
GPCR Expressing Cell Lines and Antibodies
App 20100330591 - Mancebo; Helena S. ;   et al.
2010-12-30
GPCR-expressing cell lines
Grant 7,781,209 - Mancebo , et al. August 24, 2
2010-08-24
Circularly permutated, interaction-activated proteins
Grant 7,544,477 - Balint , et al. June 9, 2
2009-06-09
Methods for affinity maturation
Grant 7,432,063 - Balint , et al. October 7, 2
2008-10-07
Reactivation-based molecular interaction sensors
Grant 7,335,478 - Balint , et al. February 26, 2
2008-02-26
GPCR expressing cell lines and antibodies
App 20070196867 - Mancebo; Helena S. ;   et al.
2007-08-23
Antibody specificity transfer using minimal essential binding determinants
App 20050255552 - Flynn, Peter ;   et al.
2005-11-17
Antibody affinity engineering by serial epitope-guided complementarity replacement
App 20050008625 - Balint, Robert F. ;   et al.
2005-01-13
Methods for affinity maturation
App 20040132066 - Balint, Robert F. ;   et al.
2004-07-08
Breakpoint fusion fragment complementation system
App 20040038317 - Balint, Robert F. ;   et al.
2004-02-26
Reactivation-based molecular interaction sensors
App 20030198971 - Balint, Robert F. ;   et al.
2003-10-23
Detection of molecular interactions by beta-lactamase reporter fragment complementation
App 20030175836 - Blau, Helen M. ;   et al.
2003-09-18
Interaction-activated, circularly permutated proteins
App 20030165825 - Balint, Robert F. ;   et al.
2003-09-04
Affinity maturation by competitive selection
App 20020155502 - Balint, Robert F. ;   et al.
2002-10-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed